P97 COVID-19的疾病严重程度和患者康复:一项比较伦敦第一波和第二波住院的观察性研究

A. Saigal, CN Niklewicz, SB Naidu, HM Bintalib, AJ Shah, G. Seligmann, A. Hunter, D. Miller, I. Abubakar, E. Wey, C. Smith, N. Jain, J. Barnett, S. Brill, J. Goldring, H. Jarvis, J. Hurst, M. Lipman, S. Mandal
{"title":"P97 COVID-19的疾病严重程度和患者康复:一项比较伦敦第一波和第二波住院的观察性研究","authors":"A. Saigal, CN Niklewicz, SB Naidu, HM Bintalib, AJ Shah, G. Seligmann, A. Hunter, D. Miller, I. Abubakar, E. Wey, C. Smith, N. Jain, J. Barnett, S. Brill, J. Goldring, H. Jarvis, J. Hurst, M. Lipman, S. Mandal","doi":"10.1136/thorax-2021-btsabstracts.207","DOIUrl":null,"url":null,"abstract":"P97 Table 1Demographics and clinical characteristics of participants at hospital admission and follow up for wave 1 and 2 admissions Wave 1 Wave 2 p-value N = 400 N = 400 Demographics and Lifestyle Age (years) (Median, IQR) 61 (50 -74) 61 (51 - 74) 0.59 Male gender (N,%) 247 (61.8%) 237 (59.3%) 0.47 Ethnicity (White) (N,%) 200 (50.0%) 195 (48.8%) 0.001* Smoking status – Never smoker (N,%) 215 (53.8%) 219 (54.8%) 0.58 BMI (kg/m2) (Median, IQR) 26.8 (24.1 - 29.4) 27.7 (24.3 - 31.6) 0.015 Underlying clinical status Clinical Frailty Score (Median, IQR) 2 (2, 4) N = 332 3 (2, 3) N = 384 0.001 Shielding Status (N,%) Extremely vulnerable HCP issued letter 32 (10.1%) 23 (7.2%) 39 (11.2%) 5 (1.4%) 0.001 Covid Admission Severity Parameters Total number of symptoms (Median, IQR) 4 (3 - 6) 3 (2 - 3) <0.0001 NEWS2 score (Median, IQR) 5 (2 - 7) N = 372 4 (3 - 6) N = 379 0.60 TEP status – For full escalation (N,%) 284/365 (77.8%) 361/400 (90.3%) <0.0001 Maximum respiratory support (N,%) CPAP NIV N= 377 10 (2.7%) 2 (0.5%) N = 400 32 (8.0%) 5 (1.3%) <0.0001 Received anti-viral or immunosuppressive drugs (N,%) 23/374 (6.2%) 127/400 (31.8%) <0.0001 ITU admission (N,%) 62/377 (16.5%) 43/400 (10.8%) 0.02 Intubation (N,%) 49/364 (13.5%) 19/400 (4.8%) <0.0001 Pulmonary Embolus (N,%) 22/360 (6.1%) 24/395 (6.1%) 0.98 Follow-up Outcomes N = 322 N = 365 Mental Health Outcomes PHQ2 score ≥ 3 (N,%) 47 (15.4%) 34 (9.9%) 0.04 TSQ score ≥ 5 (N,%) 44 (14.9%) 12 (3.3%) <0.0001 Physical Recovery and Symptoms Not returned to work (N,%) 76 (24.8%) 114 (33.6%) 0.03 Improved Sleep quality (N,%) 168 (61.5%) 265 (78.4%) <0.0001 Improved Fatigue (N,%) 241 (87.6%) 307 (88.7%) 0.91 Improved Cough (N,%) 194 (69.5%) 291 (84.8%) <0.0001 Improved Breathlessness (N,%) 213 (76.1%) 311 (89.6%) <0.0001 Total Number of Symptoms (Median, IQR) 1 (0 - 2) N=314 0 (0 – 1) N=364 Radiology outcomes (N,%) Normalised Significantly Improved Not significantly improved Worsened N=309 211 (68.3%) 55 (17.8%) 2 (0.7%) 30 (9.7%) N=279 187 (67.0%) 65 (23.3%) 13 (4.7%) 14 (5.0%) <0.0001 *p value likely attributable to differences in unknown ethnicityConclusionThese data suggest second wave pa ients, although frailer, presented with fewer symptoms and experienced improved hospital admission trajectory. They demonstrated improved self-reported mental health and physical recovery outcomes despite earlier follow-up, possibly attributed to improved in-hospital treatment. Supporting recovery remains a clinical priority given many patients had not returned to work.ReferenceSaito S, et al. First and second COVID-19 waves in Japan: comparison of disease severity and characteristics. J Infect. 2021;82(4):84-123.","PeriodicalId":266318,"journal":{"name":"COVID-19: clinical features and risk","volume":"28 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"P97 Disease severity and patient recovery in COVID-19: an observational study comparing first and second wave admissions in London\",\"authors\":\"A. Saigal, CN Niklewicz, SB Naidu, HM Bintalib, AJ Shah, G. Seligmann, A. Hunter, D. Miller, I. Abubakar, E. Wey, C. Smith, N. Jain, J. Barnett, S. Brill, J. Goldring, H. Jarvis, J. Hurst, M. Lipman, S. Mandal\",\"doi\":\"10.1136/thorax-2021-btsabstracts.207\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"P97 Table 1Demographics and clinical characteristics of participants at hospital admission and follow up for wave 1 and 2 admissions Wave 1 Wave 2 p-value N = 400 N = 400 Demographics and Lifestyle Age (years) (Median, IQR) 61 (50 -74) 61 (51 - 74) 0.59 Male gender (N,%) 247 (61.8%) 237 (59.3%) 0.47 Ethnicity (White) (N,%) 200 (50.0%) 195 (48.8%) 0.001* Smoking status – Never smoker (N,%) 215 (53.8%) 219 (54.8%) 0.58 BMI (kg/m2) (Median, IQR) 26.8 (24.1 - 29.4) 27.7 (24.3 - 31.6) 0.015 Underlying clinical status Clinical Frailty Score (Median, IQR) 2 (2, 4) N = 332 3 (2, 3) N = 384 0.001 Shielding Status (N,%) Extremely vulnerable HCP issued letter 32 (10.1%) 23 (7.2%) 39 (11.2%) 5 (1.4%) 0.001 Covid Admission Severity Parameters Total number of symptoms (Median, IQR) 4 (3 - 6) 3 (2 - 3) <0.0001 NEWS2 score (Median, IQR) 5 (2 - 7) N = 372 4 (3 - 6) N = 379 0.60 TEP status – For full escalation (N,%) 284/365 (77.8%) 361/400 (90.3%) <0.0001 Maximum respiratory support (N,%) CPAP NIV N= 377 10 (2.7%) 2 (0.5%) N = 400 32 (8.0%) 5 (1.3%) <0.0001 Received anti-viral or immunosuppressive drugs (N,%) 23/374 (6.2%) 127/400 (31.8%) <0.0001 ITU admission (N,%) 62/377 (16.5%) 43/400 (10.8%) 0.02 Intubation (N,%) 49/364 (13.5%) 19/400 (4.8%) <0.0001 Pulmonary Embolus (N,%) 22/360 (6.1%) 24/395 (6.1%) 0.98 Follow-up Outcomes N = 322 N = 365 Mental Health Outcomes PHQ2 score ≥ 3 (N,%) 47 (15.4%) 34 (9.9%) 0.04 TSQ score ≥ 5 (N,%) 44 (14.9%) 12 (3.3%) <0.0001 Physical Recovery and Symptoms Not returned to work (N,%) 76 (24.8%) 114 (33.6%) 0.03 Improved Sleep quality (N,%) 168 (61.5%) 265 (78.4%) <0.0001 Improved Fatigue (N,%) 241 (87.6%) 307 (88.7%) 0.91 Improved Cough (N,%) 194 (69.5%) 291 (84.8%) <0.0001 Improved Breathlessness (N,%) 213 (76.1%) 311 (89.6%) <0.0001 Total Number of Symptoms (Median, IQR) 1 (0 - 2) N=314 0 (0 – 1) N=364 Radiology outcomes (N,%) Normalised Significantly Improved Not significantly improved Worsened N=309 211 (68.3%) 55 (17.8%) 2 (0.7%) 30 (9.7%) N=279 187 (67.0%) 65 (23.3%) 13 (4.7%) 14 (5.0%) <0.0001 *p value likely attributable to differences in unknown ethnicityConclusionThese data suggest second wave pa ients, although frailer, presented with fewer symptoms and experienced improved hospital admission trajectory. They demonstrated improved self-reported mental health and physical recovery outcomes despite earlier follow-up, possibly attributed to improved in-hospital treatment. Supporting recovery remains a clinical priority given many patients had not returned to work.ReferenceSaito S, et al. First and second COVID-19 waves in Japan: comparison of disease severity and characteristics. J Infect. 2021;82(4):84-123.\",\"PeriodicalId\":266318,\"journal\":{\"name\":\"COVID-19: clinical features and risk\",\"volume\":\"28 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"COVID-19: clinical features and risk\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/thorax-2021-btsabstracts.207\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"COVID-19: clinical features and risk","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/thorax-2021-btsabstracts.207","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

表1第1和第2波入院时参与者的人口学和临床特征以及第1和第2波入院时随访的人口学和临床特征p值N = 400 N = 400人口统计学和生活方式年龄(年龄)(中位数,IQR) 61(50 -74) 61(51 -74) 0.59男性性别(N,%) 247(61.8%) 237(59.3%) 0.47种族(白人)(N,%) 200(50.0%) 195(48.8%) 0.001*吸烟状况-从不吸烟(N,%) 215 (53.8%) 219 (54.8%) 0.58 BMI (kg/m2)(中位数,IQR) 26.8(24.1 - 29.4) 27.7(24.3 - 31.6) 0.015潜在临床状态临床虚弱评分(中位数,IQR) 2 (2,4) N = 332 3 (2,3) N = 384 0.001防护状态(N,%)极度脆弱的HCP签发信32(10.1%)23(7.2%)39(11.2%)5(1.4%)0.001新冠入院严重程度参数症状总数(中位数,IQR) 4 (3 - 6) 3 (2 - 3) <0.0001 NEWS2评分(中位数,IQR),差)5 (2 - 7)N = 372 4 (3 - 6) N = 379 0.60 TEP中的地位,全面升级(N, %) 284/365(77.8%)的361/400(90.3%)< 0.0001最大呼吸支持(N, %) CPAP和合N = 377 10 (2.7%) 2 (0.5%) N = 400 32例(8.0%)5(1.3%)< 0.0001收到抗病毒或免疫抑制药物(N, %) 23/374(6.2%)的127/400(31.8%)< 0.0001电联入学(N, %) 62/377(16.5%)的43/400(10.8%)0.02插管(N, %) 49/364(13.5%)的19/400(4.8%)< 0.0001肺动脉栓子(N, %) 22/360(6.1%)的24/395(6.1%)0.98的后续结果N = 322 N = 365心理健康结果PHQ2分数≥3 (N, %) 47 (15.4%) 34 (9.9%) 0.04 TSQ评分≥5 (N, %) 44(14.9%) 12(3.3%) < 0.0001体能恢复和症状不回到工作岗位(N, %) 76(24.8%) 114(33.6%) 0.03改善睡眠质量(N, %) 168(61.5%) 265(78.4%) < 0.0001改善疲劳(N, %) 241(87.6%) 307(88.7%) 0.91改善咳嗽(N, %) 194(69.5%) 291(84.8%) < 0.0001改善呼吸困难(N, %) 213(76.1%) 311(89.6%) < 0.0001的症状总数(中位数,IQR) 1 (0 - 2) N=314 0 (0 - 1) N=364放射学结果(N,%)正常化显著改善未显著改善恶化N=309 211 (68.3%) 55 (17.8%) 2 (0.7%) 30 (9.7%) N=279 187 (67.0%) 65 (23.3%) 13 (4.7%) 14 (5.0%) <0.0001 *p值可能归因于未知种族差异结论这些数据提示第二波患者虽然较弱,但症状较少,住院轨迹改善。尽管随访时间较早,但他们表现出自我报告的心理健康和身体恢复结果有所改善,这可能归因于住院治疗的改善。鉴于许多患者尚未重返工作岗位,支持康复仍然是临床优先事项。参考文献:saito S等。日本第一波和第二波COVID-19:疾病严重程度和特征的比较中华检验医学杂志,2013;32(4):391 - 391。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
P97 Disease severity and patient recovery in COVID-19: an observational study comparing first and second wave admissions in London
P97 Table 1Demographics and clinical characteristics of participants at hospital admission and follow up for wave 1 and 2 admissions Wave 1 Wave 2 p-value N = 400 N = 400 Demographics and Lifestyle Age (years) (Median, IQR) 61 (50 -74) 61 (51 - 74) 0.59 Male gender (N,%) 247 (61.8%) 237 (59.3%) 0.47 Ethnicity (White) (N,%) 200 (50.0%) 195 (48.8%) 0.001* Smoking status – Never smoker (N,%) 215 (53.8%) 219 (54.8%) 0.58 BMI (kg/m2) (Median, IQR) 26.8 (24.1 - 29.4) 27.7 (24.3 - 31.6) 0.015 Underlying clinical status Clinical Frailty Score (Median, IQR) 2 (2, 4) N = 332 3 (2, 3) N = 384 0.001 Shielding Status (N,%) Extremely vulnerable HCP issued letter 32 (10.1%) 23 (7.2%) 39 (11.2%) 5 (1.4%) 0.001 Covid Admission Severity Parameters Total number of symptoms (Median, IQR) 4 (3 - 6) 3 (2 - 3) <0.0001 NEWS2 score (Median, IQR) 5 (2 - 7) N = 372 4 (3 - 6) N = 379 0.60 TEP status – For full escalation (N,%) 284/365 (77.8%) 361/400 (90.3%) <0.0001 Maximum respiratory support (N,%) CPAP NIV N= 377 10 (2.7%) 2 (0.5%) N = 400 32 (8.0%) 5 (1.3%) <0.0001 Received anti-viral or immunosuppressive drugs (N,%) 23/374 (6.2%) 127/400 (31.8%) <0.0001 ITU admission (N,%) 62/377 (16.5%) 43/400 (10.8%) 0.02 Intubation (N,%) 49/364 (13.5%) 19/400 (4.8%) <0.0001 Pulmonary Embolus (N,%) 22/360 (6.1%) 24/395 (6.1%) 0.98 Follow-up Outcomes N = 322 N = 365 Mental Health Outcomes PHQ2 score ≥ 3 (N,%) 47 (15.4%) 34 (9.9%) 0.04 TSQ score ≥ 5 (N,%) 44 (14.9%) 12 (3.3%) <0.0001 Physical Recovery and Symptoms Not returned to work (N,%) 76 (24.8%) 114 (33.6%) 0.03 Improved Sleep quality (N,%) 168 (61.5%) 265 (78.4%) <0.0001 Improved Fatigue (N,%) 241 (87.6%) 307 (88.7%) 0.91 Improved Cough (N,%) 194 (69.5%) 291 (84.8%) <0.0001 Improved Breathlessness (N,%) 213 (76.1%) 311 (89.6%) <0.0001 Total Number of Symptoms (Median, IQR) 1 (0 - 2) N=314 0 (0 – 1) N=364 Radiology outcomes (N,%) Normalised Significantly Improved Not significantly improved Worsened N=309 211 (68.3%) 55 (17.8%) 2 (0.7%) 30 (9.7%) N=279 187 (67.0%) 65 (23.3%) 13 (4.7%) 14 (5.0%) <0.0001 *p value likely attributable to differences in unknown ethnicityConclusionThese data suggest second wave pa ients, although frailer, presented with fewer symptoms and experienced improved hospital admission trajectory. They demonstrated improved self-reported mental health and physical recovery outcomes despite earlier follow-up, possibly attributed to improved in-hospital treatment. Supporting recovery remains a clinical priority given many patients had not returned to work.ReferenceSaito S, et al. First and second COVID-19 waves in Japan: comparison of disease severity and characteristics. J Infect. 2021;82(4):84-123.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信